Free Trial

OKYO Pharma (OKYO) News Today

OKYO Pharma logo
$1.61 -0.01 (-0.62%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$1.62 +0.01 (+0.56%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OKYO Latest News

OKYO Pharma Announces Director Acquires Shares
OKYO Pharma prices $20M offering to fund late-stage eye drug trial
OKYO Pharma Announces Public Offering of Ordinary Shares
OKYO Pharma appoints Flavio Mantelli as chief medical officer
OKYO Pharma Announces Successful Type C Meeting with the FDA
OKYO Pharma names ophthalmology veteran Robert Dempsey as CEO
LIVE: OKYO Pharma Ltd Rings the Opening Bell
OKYO Pharma management team to ring Nasdaq opening bell
OKYO Pharma to Ring the Opening Bell at Nasdaq
OKYO Pharma Announces Chairman and Founder Acquires Shares
OKYO Pharma stock rises after Chairman increases stake
OKYO Pharma Announces Chairman and Founder Acquires Shares
OKYO Pharma to Present at OIS XV in San Diego
OKYO Pharma Announces Chairman and Founder Acquires Shares
Get OKYO Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OKYO Media Mentions By Week

OKYO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OKYO
News Sentiment

1.87

0.61

Average
Medical
News Sentiment

OKYO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OKYO Articles
This Week

1

2

OKYO Articles
Average Week

Get the Latest News and Ratings for OKYO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for OKYO Pharma and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:OKYO) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners